Skip to content
Home/Companies/Biotech/Abalos Therapeutics
AT

Abalos Therapeutics

Biotech·Germany·Active·7yr hold

Abalos Therapeutics is a biotech company, headquartered in Germany.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Abalos Therapeutics?

Abalos Therapeutics is currently owned by Gruenderfonds Ruhr through Gruenderfonds Ruhr I (2017 vintage), since 2019. Across its history, Abalos Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Gruenderfonds Ruhr
Most recent investor
Gruenderfonds Ruhr
Gruenderfonds Ruhr I · 2017 · VC
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Boehringer Ingelheim Venture Fund and Gruenderfonds Ruhr since 2019.
Co-invest · 2 holders · 2019 · present
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundActive
2019 · present · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
MOIC
–
Gruenderfonds Ruhr
Gruenderfonds RuhrActive
2019 · present · Gruenderfonds Ruhr I · 2017 · VC
MOIC
–

More from Gruenderfonds Ruhr I

Other portfolio companies in the same fund.

LIDROTEC
Active
IndustrialsGermany· 2022
Spherity
Active
CybersecurityGermany· 2022
VMRay
Active
CybersecurityGermany· 2022
Advosense
Active
MedTechGermany· 2020
Masterplan
Exited 2025
SoftwareGermany· 2020
to
DIMATE
Active
IndustrialsGermany· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings